glycine has been researched along with Myositis Ossificans in 1 studies
Myositis Ossificans: A disease characterized by bony deposits or the ossification of muscle tissue.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, T | 1 |
| Kanomata, K | 1 |
| Nojima, J | 1 |
| Kokabu, S | 1 |
| Akita, M | 1 |
| Ikebuchi, K | 1 |
| Jimi, E | 1 |
| Komori, T | 1 |
| Maruki, Y | 1 |
| Matsuoka, M | 1 |
| Miyazono, K | 1 |
| Nakayama, K | 1 |
| Nanba, A | 1 |
| Tomoda, H | 1 |
| Okazaki, Y | 1 |
| Ohtake, A | 1 |
| Oda, H | 1 |
| Owan, I | 1 |
| Yoda, T | 1 |
| Haga, N | 1 |
| Furuya, H | 1 |
| Katagiri, T | 1 |
1 other study available for glycine and Myositis Ossificans
| Article | Year |
|---|---|
A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor.
Topics: Activin Receptors, Type I; Amino Acid Substitution; Animals; Aspartic Acid; Bone Morphogenetic Prote | 2008 |